Saturna Capital Corp Merck & Co., Inc. Transaction History

Saturna Capital Corp

$7.16 Billion
Q1 2024

A detailed history of Saturna Capital Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Saturna Capital Corp holds 864,424 shares of MRK stock, worth $109 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares

864,424

Previous 759,838 13.76%

Holding current value

$109 Million

Previous $82.8 Million 37.69%

% of portfolio

1.59%

Previous 1.31%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $11.8 Million - $13.8 Million	104,586 Added 13.76%	864,424 $114 Million
Q4 2023 Feb 06, 2024	BUY	$100.18 - $109.02 $10 Million - $10.9 Million	100,052 Added 15.16%	759,838 $82.8 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $50,445 - $56,021	-490 Reduced 0.07%	659,786 $67.9 Million
Q2 2023 Aug 04, 2023	BUY	$108.61 - $118.38 $223,736 - $243,862	2,060 Added 0.31%	660,276 $76.2 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $19.6 Million - $21.9 Million	190,437 Added 40.71%	658,216 $70 Million

Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $39.3 Million - $50.4 Million	449,810 Added 2503.26%	467,779 $51.9 Million
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $26,288 - $29,532	311 Added 1.76%	17,969 $1.55 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $72,636 - $82,336	870 Added 5.18%	17,658 $1.61 Million
Q1 2022 May 10, 2022	BUY	$73.51 - $82.4 $260,225 - $291,696	3,540 Added 26.72%	16,788 $1.38 Million
Q4 2021 Feb 09, 2022	BUY	$72.28 - $90.54 $122,370 - $153,284	1,693 Added 14.65%	13,248 $1.02 Million
Q3 2021 Nov 08, 2021	SELL	$71.68 - $78.83 $765,685 - $842,062	-10,682 Reduced 48.04%	11,555 $868,000
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $112,930 - $133,020	1,640 Added 7.96%	22,237 $1.71 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $433,706 - $481,324	6,043 Added 41.52%	20,597 $1.69 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $110,880 - $153,685	1,750 Added 13.67%	14,554 $1.16 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $508,442 - $554,221	6,683 Added 109.18%	12,804 $1.08 Million
Q2 2019 Jul 31, 2019	BUY	$69.84 - $81.59 $427,490 - $499,412	6,121 New	6,121 $513,000
Q4 2017 Feb 06, 2018	SELL	$51.62 - $61.64 $362,836 - $433,267	-7,029 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	7,029	7,029 $450,000

Others Institutions Holding MRK

# of Institutions

3,769

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $320B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Account

Saturna Capital Corp Merck & Co., Inc. Transaction History